Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Villa Park › NPI 1033327143
Physician

Sattar, Soha

Sattar, Soha was paid $642K by Medicaid between Jan 2018 and Dec 2024, across 19 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 63% of everything it billed.

33Billing provider infoSATTAR, SOHA
VILLA PARK, IL 60181
33aNPI1033327143assigned 05/21/2007
28Total paid$642K
24GClaims11,501
24DCodes billed19
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Illinois

Rank by total paid#161 of 2,947
Median peer was paid$43K
This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,554$73K
20192,322$119K
20202,241$124K
20211,782$109K
20221,680$94K
2023975$56K
2024incomplete947$67K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 63% 5,661 4,031 $404K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 28% 3,920 3,161 $179K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1.5% 210 181 $9K
93000 1.3% 399 353 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 138 74 $7K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 134 111 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 55 42 $4K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 47 39 $4K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 43 40 $4K
94060 <1% 53 44 $3K
94010 <1% 61 53 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 91 85 $2K
7 more codes
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 92 $2K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 22 $2K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 19 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 18 $1K
36415 Collection of venous blood by venipuncture <1% 489 $1K
0013A <1% 12 $505.68
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 37 $488.03

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.